Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013.
Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R. Farahani M, et al. Among authors: keapoletswe k. AIDS. 2016 Jan 28;30(3):477-85. doi: 10.1097/QAD.0000000000000921. AIDS. 2016. PMID: 26636931 Free PMC article.
Impact of Health System Inputs on Health Outcome: A Multilevel Longitudinal Analysis of Botswana National Antiretroviral Program (2002-2013).
Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld AF, Nkomazana O, Marlink R. Farahani M, et al. Among authors: keapoletswe k. PLoS One. 2016 Aug 4;11(8):e0160206. doi: 10.1371/journal.pone.0160206. eCollection 2016. PLoS One. 2016. PMID: 27490477 Free PMC article.
Variation in attrition at subnational level: review of the Botswana National HIV/AIDS Treatment (Masa) programme data (2002-2013).
Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R. Farahani M, et al. Among authors: keapoletswe k. Trop Med Int Health. 2016 Jan;21(1):18-27. doi: 10.1111/tmi.12623. Epub 2015 Nov 12. Trop Med Int Health. 2016. PMID: 26485172 Free PMC article.
Testing modality associated with fast-track ART initiation in Botswana.
Lavoie MC, Blanco N, Keapoletswe K, Marima R, Ntwayagae OA, Sebina KB, Loeto P, Mogomotsi PG, Saleeb PG, Ndwapi N, Stafford KA. Lavoie MC, et al. Among authors: keapoletswe k. Trop Med Int Health. 2022 May;27(5):537-543. doi: 10.1111/tmi.13745. Epub 2022 Mar 23. Trop Med Int Health. 2022. PMID: 35298082 Free article.
Two and a half years of routine HIV testing in Botswana.
Steen TW, Seipone K, Gomez Fde L, Anderson MG, Kejelepula M, Keapoletswe K, Moffat HJ. Steen TW, et al. Among authors: keapoletswe k. J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):484-8. doi: 10.1097/QAI.0b013e318030ffa9. J Acquir Immune Defic Syndr. 2007. PMID: 17211281
Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.
Dryden-Peterson S, Jayeoba O, Hughes MD, Jibril H, Keapoletswe K, Tlale J, Modise TA, Asmelash A, Moyo S, van Widenfelt E, Makhema J, Essex M, Shapiro RL, Lockman S. Dryden-Peterson S, et al. Among authors: keapoletswe k. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):353-7. doi: 10.1097/QAI.0b013e31822d4063. J Acquir Immune Defic Syndr. 2011. PMID: 21792062 Free PMC article.
An augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trial.
Dryden-Peterson S, Bennett K, Hughes MD, Veres A, John O, Pradhananga R, Boyer M, Brown C, Sakyi B, van Widenfelt E, Keapoletswe K, Mine M, Moyo S, Asmelash A, Siedner M, Mmalane M, Shapiro RL, Lockman S. Dryden-Peterson S, et al. Among authors: keapoletswe k. PLoS One. 2015 Feb 18;10(2):e0117181. doi: 10.1371/journal.pone.0117181. eCollection 2015. PLoS One. 2015. PMID: 25693050 Free PMC article. Clinical Trial.